microRNA-143-3p contributes to inflammatory reactions by targeting FOSL2 in PBMCs from patients with autoimmune diabetes mellitus.

Shan PanMengyu LiHaibo YuZhiguo XieXia LiXianlan DuanGan HuangZhiguang Zhou

Published in: Acta diabetologica (2020)

The expression of miR-143-3p in PBMCs from ADM patients is upregulated. miR-143-3p could function in the pathogenesis of ADM by modulating the inflammatory reaction through FOSL2.

Keyphrases

end stage renal disease
ejection fraction
oxidative stress
newly diagnosed
chronic kidney disease
poor prognosis
multiple sclerosis
peritoneal dialysis
prognostic factors
signaling pathway
binding protein
adipose tissue
long non coding rna
skeletal muscle
weight loss